NCT06290674

Brief Summary

Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 11, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

February 26, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

1.3 years

First QC Date

February 26, 2024

Last Update Submit

July 19, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Waist/ hip ratio

    anthropometric outcome measure for abdominal adiposity

    Pretreatment and Posttreatment of six weeks study protocol.

  • Skin fold caliper

    subcutaneous fat outcome measure

    Pretreatment and Posttreatment of six weeks study protocol.

Secondary Outcomes (1)

  • Lipid profile

    Pretreatment and Posttreatment of six weeks study protocol.

Study Arms (2)

Study Group (A) (ESWT)

ACTIVE COMPARATOR

30 participants will receive Extracorporeal Shockwave (one session per week for 6 weeks), in addition to a balanced low-calorie diet (1500 k/cal for 6 weeks).

Other: Extracorporeal Shockwave therapyOther: Balanced low-calorie diet

Control Group (B)

PLACEBO COMPARATOR

30 participant will receive Balanced low-calorie diet (1500 k/cal for 6 weeks), only.

Other: Balanced low-calorie diet

Interventions

2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.

Study Group (A) (ESWT)

1500 k/cal for 6 weeks

Control Group (B)Study Group (A) (ESWT)

Eligibility Criteria

Age45 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsCurrent study focuses on Obese Postmenopausal women, based on well-known associated abdominal obesity.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Their age range 45-60 years old.
  • Their body mass index range 30-35 kg/m square.
  • Only, obese postmenopausal women with at least one year after stoppage of menses.

You may not qualify if:

  • Receiving pharmacological treatment.
  • Receiving any form of electrotherapy.
  • Whom with metabolic, hematological or renal dysfunction.
  • Whom have dermatological or cardiovascular or respiratory, digestive or rheumatic disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helwan General Hospital

Cairo, Helwan, Cairo Governate, 02, Egypt

Location

MeSH Terms

Conditions

Obesity, Abdominal

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Azza B Nashed, PHD

    Professor of Physical Therapy for Women's Health

    STUDY CHAIR
  • Sherif S El-Shebeni, MSc.

    Consultant of Obstetrics and Gynecology

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double masking (Investigator and Participant)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Clinical randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical Therapy

Study Record Dates

First Submitted

February 26, 2024

First Posted

March 4, 2024

Study Start

September 11, 2022

Primary Completion

January 1, 2024

Study Completion

February 1, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Will Share whole raw data, therapeutic protocol details for future systematic review and/ or meta-analysis. wish to be valuable

Locations